NASDAQ: CRDF
Cardiff Oncology Inc Stock Ownership - Who owns Cardiff Oncology?

Insider buying vs selling

Have Cardiff Oncology Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Mani MohindruCEO2026-07-1434,364$1.46
$50.00kBuy
Gary W. PaceDirector2026-07-14687,285$1.46
$1,000.00kBuy
Mani MohindruChief Executive Officer2026-06-1824,703$1.21
$29.89kBuy
Gary W. PaceDirector2026-06-1830,000$1.22
$36.60kBuy

1 of 1

CRDF insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CRDF insiders and whales buy or sell their stock.

CRDF Shareholders

What type of owners hold Cardiff Oncology Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Robert Merrill Hunter6.51%5,065,004$4.98MInsider
Gary W. Pace4.93%3,837,098$3.78MInsider
Ra Capital Management LP4.23%3,290,000$3.24MInsider
Bridger Management LLC3.82%2,968,115$2.92MInsider
Kira Sheinerman1.17%909,090$894.54kInsider
William J. Welch1.08%842,645$829.16kInsider
Gabriel Cerrone0.93%725,776$714.16kInsider
James E. Levine0.16%127,716$125.67kInsider
Lale White0.15%113,788$111.97kInsider
Steve Zaniboni0.12%96,968$95.42kInsider

1 of 3

CRDF vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CRDF0.02%23.54%Net BuyingNet Buying
TELO0.00%23.07%Net Buying
LONA0.01%99.99%Net Buying
ELOX0.00%100.00%Net Buying
CING0.01%30.09%Net Buying

Cardiff Oncology Stock Ownership FAQ

Who owns Cardiff Oncology?

Cardiff Oncology (NASDAQ: CRDF) is owned by 0.02% institutional shareholders, 23.54% Cardiff Oncology insiders, and 76.44% retail investors. Robert Merrill Hunter is the largest individual Cardiff Oncology shareholder, owning 5.07M shares representing 6.51% of the company. Robert Merrill Hunter's Cardiff Oncology shares are currently valued at $4.88M.

If you're new to stock investing, here's how to buy Cardiff Oncology stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.